Meeting Highlights Information Registration Visa Letter Application Programme Overview Exhibition Virtual Exhibition Hotels Exhibition Virtual Exhibition Satellite Programme


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Visual outcomes after bilateral Tecnis eyhance implantation-6 months follow-up

Poster Details


First Author: M.Belovari CROATIA

Co Author(s): B. Kuzmanovic Elabjer   D. Grgic   D. Saric              

Abstract Details

Purpose:

To evaluate visual outcomes after bilateral Tecnis Eyhance intraocular lens (IOL) implantation in patients with cataracts who  came to our clinic for a refractive solution, and were contraindicated for multifocal and/or extended depth od focus (EDOF)  IOLs.

Setting:

Optical Express, Zagreb, Croatia

Methods:

In this prospective study  40 eyes of 20 patients were enrolled. Bilateral lens phacoemulsification of cataract with implantation of a monofocal  Tecnis Eyhance IOL (Johnson & Johnson Vision)  were performed by the  same surgeon. Second eye was operated 1 month after the first eye. Visual outcomes, including uncorrected  distance visual acuity (UCDVA, intermediate (UCIVA) and near (UCNVA) visual acuity, photic phenomena (halo and glare) and patient's satisfaction were assessed preoperatively and during the 6 month follow up period. Exclusion criteria were moderate to severe forms of maculopathy, epiretinal membrane and amblyopia.

Results:

Data collected on 40 eyes  marked that  UCDVA and UCIVA  achieved the satisfying  visual outcomes 7 days following  first eye surgery, and remained stable during  6 months follow up period. Improvement of UCIVA and more acceptable UCNVA occured 7 days after second eye surgery and also remained stable. Patients reported a high level of satisfaction and an absence of glare or halo 6 months postoperatively.

Conclusions:

In this study, the Tecnis Eyhance IOL provided excellent visual performance at distant and intermediate distances resulting in high levels of patients satisfaction  and almost complete spectacle independence in patients with cataracts who were not suitable for other types of   premium IOLs.

Financial Disclosure:

None

Back to Poster listing